Income tax expense · 2013–2025

Ultragenyx Pharmaceutical income tax expense

$4.0M+100.0% · FY2025

Ultragenyx Pharmaceutical (RARE) reported $4.0M in income tax expense for fiscal 2025, +100.0% year on year.

$02013$02014$02015$35,0002016−$16.2M2017$514,0002018$3.3M2019$1.2M2020$1.0M2021$5.7M2022−$2.0M2023$2.0M2024$4.0M2025
Ultragenyx Pharmaceutical — Income tax expense, 2013–2025
Fiscal yearIncome tax expenseChangeFiling
FY20252025-12-31$4.0M+100.0%Open →
FY20242024-12-31$2.0M+$4.0MOpen →
FY20232023-12-31−$2.0M−$7.7MOpen →
FY20222022-12-31$5.7M+445.6%Open →
FY20212021-12-31$1.0M−13.5%Open →
FY20202020-12-31$1.2M−63.2%Open →
FY20192019-12-31$3.3M+538.7%Open →
FY20182018-12-31$514,000+$16.7MOpen →
FY20172017-12-31−$16.2M−$16.2MOpen →
FY20162016-12-31$35,000+$35,000Open →
FY20152015-12-31$0$0Open →
FY20142014-12-31$0$0Open →
FY20132013-12-31$0—Open →

Income tax expense — Income tax expense is the tax a company charged against profit in its income statement for the year. It is not the same as the cash it handed to tax authorities: deferred tax, provisions and timing differences separate the two, often by billions. The cash figure is a different line in the cash-flow statement.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026

Income tax expense at companies of similar size

Full ranking by income tax expense →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Ultragenyx Pharmaceutical income tax expense |url=https://companiesranked.com/en/company/ultragenyx-pharmaceutical/income-tax-expense |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Ultragenyx Pharmaceutical income tax expense. CompaniesRanked. https://companiesranked.com/en/company/ultragenyx-pharmaceutical/income-tax-expense

BibTeX

@misc{companiesranked-en-company-ultragenyx-pharmaceutical-income-tax-expense-2026,
  author       = {{CompaniesRanked}},
  title        = {{Ultragenyx Pharmaceutical income tax expense}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/ultragenyx-pharmaceutical/income-tax-expense}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-K · 0001193125-26-057329 · February 18, 2026

{{cite web |title=Ultragenyx Pharmaceutical income tax expense — 10-K (0001193125-26-057329) |url=https://www.sec.gov/Archives/edgar/data/1515673/000119312526057329/rare-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-18}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Ultragenyx Pharmaceutical overview